Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind Double-dummy Trial Comparing MENOPUR Solution for Injection in a Pre-filled Pen and MENOPUR Powder and Solvent for Solution for Injection (Menotropins for Injection) in a GnRH Agonist Cycle in Women Aged 18-42 Years Undergoing an Assisted Reproductive Technology Program
Conditions
Interventions
MENOPUR solution for injection in pre-filled pen, 1200 IU/1.92 mL
MENOPUR powder and solvent for solution for injection, 75 IU
+2 more
Locations
20
United States
Fertility Treatment Center
Tempe, Arizona, United States
Fertility Specialists Medical Group - San Diego Center for Reproductive Surgery
San Diego, California, United States
Center for Advanced Reproductive Services PC
Farmington, Connecticut, United States
Yale Fertility Center
New Haven, Connecticut, United States
Fertility and IVF Center of Miami
Miami, Florida, United States
Center for Reproductive Medicine
Winter Park, Florida, United States
Start Date
October 25, 2019
Primary Completion Date
May 28, 2021
Completion Date
July 16, 2021
Last Updated
November 7, 2023
NCT06826365
NCT07153367
NCT04872660
NCT07462065
NCT05903859
NCT06742437
Lead Sponsor
Ferring Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions